{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:43Z","timestamp":1776329803180,"version":"3.50.1"},"reference-count":21,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.6002\/ect.mesot2023.l7","type":"journal-issue","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:46:38Z","timestamp":1708065998000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Stephan A. Organ shortage: can we decrease the demand? Exp Clin Transplant. 2017;15(Suppl 1):6-9. doi:10.6002\/ect.mesot2016.L27","DOI":"10.6002\/ect.mesot2016.L27"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Francis L. Delmonico, MD: the science of organ donation. Transplantation. 2016;100(7):1394-1395. doi:10.1097\/TP.0000000000001306","DOI":"10.1097\/TP.0000000000001306"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Lin J, Thompson TJ, Cheng YJ, et al. Projection of the future diabetes burden in the United States through 2060. Popul Health Metr. 2018;16(1):9. doi:10.1186\/s12963-018-0166-4","DOI":"10.1186\/s12963-018-0166-4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev. 2011;91(2):733-794. doi:10.1152\/physrev.00055.2009","DOI":"10.1152\/physrev.00055.2009"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2018;94(1):26-39. doi:10.1016\/j.kint.2017.12.027","DOI":"10.1016\/j.kint.2017.12.027"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Meraz-Munoz AY, Weinstein J, Wald R. eGFR Decline after SGLT2 inhibitor initiation: the tortoise and the hare reimagined. Kidney360. 2021;2(6):1042-1047. doi:10.34067\/KID.0001172021","DOI":"10.34067\/KID.0001172021"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. McGill JB, Subramanian S. Safety of sodium-glucose co-transporter 2 inhibitors. Am J Cardiol. 2019;124 Suppl 1:S45-S52. doi:10.1016\/j.amjcard.2019.10.029","DOI":"10.1016\/j.amjcard.2019.10.029"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Oshima M, Shimizu M, Yamanouchi M, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17(11):740-750. doi:10.1038\/s41581-021-00462-y","DOI":"10.1038\/s41581-021-00462-y"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Jha JC, Jandeleit-Dahm KA, Cooper ME. New insights into the use of biomarkers of diabetic nephropathy. Adv Chronic Kidney Dis. 2014;21(3):318-326. doi:10.1053\/j.ackd.2014.03.008","DOI":"10.1053\/j.ackd.2014.03.008"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Wheeler DC, Stefansson BV, Batiushin M, et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant. 2020;35(10):1700-1711. doi:10.1093\/ndt\/gfaa234","DOI":"10.1093\/ndt\/gfaa234"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Lv R, Xu L, Che L, Liu S, Wang Y, Dong B. Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus. Front Endocrinol (Lausanne). 2023;14:1125693. doi:10.3389\/fendo.2023.1125693","DOI":"10.3389\/fendo.2023.1125693"},{"key":"ref11","unstructured":"12. Energy Networks Association. Health and Wellbeing Framework. September 2010. https:\/\/www.energynetworks.org\/industry-hub\/resource-library\/health-and-wellbeing-framework.pdf"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Masereeuw R, Stamatialis D. Creating a bioartificial kidney. Int J Artif Organs. 2017;40(7):323-327. doi:10.5301\/IJAO.5000581","DOI":"10.5301\/ijao.5000581"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Tang YS, Tsai YC, Chen TW, Li SY. Artificial kidney engineering: the development of dialysis membranes for blood purification. Membranes (Basel). 2022;12(2):177. doi:10.3390\/membranes12020177","DOI":"10.3390\/membranes12020177"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823-1838. doi:10.1016\/j.jacc.2019.08.1017","DOI":"10.1016\/j.jacc.2019.08.1017"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Redman M, King A, Watson C, King D. What is CRISPR\/Cas9? Arch Dis Child Educ Pract Ed. 2016;101(4):213-215. doi:10.1136\/archdischild-2016-310459","DOI":"10.1136\/archdischild-2016-310459"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Boulet J, Cunningham JW, Mehra MR. Cardiac xenotransplantation: challenges, evolution, and advances. JACC Basic Transl Sci. 2022;7(7):716-729. doi:10.1016\/j.jacbts.2022.05.003","DOI":"10.1016\/j.jacbts.2022.05.003"},{"key":"ref17","unstructured":"18. Kevany S. US FDA declares genetically modified pork 'safe to eat'. The Guardian. December 17, 2020. https:\/\/www.theguardian.com\/environment\/2020\/dec\/17\/us-fda-declares-genetically-modified-pork-safe-to-eat"},{"key":"ref18","unstructured":"19. Wikipedia. Intensive pig farming. https:\/\/en.wikipedia.org\/wiki\/Intensive_pig_farming"},{"key":"ref19","unstructured":"20. Zhang S. Cardiac xenotransplantation: a first in-human experience. American College of Cardiology. March 1, 2022. https:\/\/www.acc.org\/Membership\/Sections-and-Councils\/Fellows-in-Training-Section\/Section-Updates\/2022\/03\/01\/20\/45\/Cardiac-Xenotransplantation"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Porrett PM, Orandi BJ, Kumar V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. Am J Transplant. 2022;22(4):1037-1053. doi:10.1111\/ajt.16930","DOI":"10.1111\/ajt.16930"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T01:23:53Z","timestamp":1708305833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/1\/1\/14\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":21,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2023.l7","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}